BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25283264)

  • 21. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
    Thorup C; Kornfeld M; Winaver JM; Goligorsky MS; Moore LC
    Pflugers Arch; 1998 Feb; 435(3):432-4. PubMed ID: 9426302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles.
    Khan MT; Razi MT; Jan SU; Mukhtiar M; Gul R; IzharUllah -; Hussain A; Hashmi AM; Ahmad MT; Shahwani NA; Rabbani I
    Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1067-1074. PubMed ID: 29731445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between extracellular and intracellular administered angiotensin II in isolated rat portal vein rings.
    Gurzu B; Costuleanu M; Petrescu G
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):652-6. PubMed ID: 15832993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
    Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
    Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; Rodríguez R; Carceller E; García-Rafanell J; Forn J
    J Med Chem; 1996 May; 39(11):2197-206. PubMed ID: 8667363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
    Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
    J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
    Wang TT; Liu Y; Chen L
    Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
    López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
    Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities.
    Wu Z; Xia MB; Bertsetseg D; Wang YH; Bao XL; Zhu WB; Tao-Xu ; Chen PR; Tang HS; Yan YJ; Chen ZL
    Bioorg Chem; 2020 Aug; 101():104042. PubMed ID: 32650179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.
    Liu J; Liu Q; Yang X; Xu S; Zhang H; Bai R; Yao H; Jiang J; Shen M; Wu X; Xu J
    Bioorg Med Chem; 2013 Dec; 21(24):7742-51. PubMed ID: 24200932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogs.
    López GV; Batthyány C; Blanco F; Botti H; Trostchansky A; Migliaro E; Radi R; González M; Cerecetto H; Rubbo H
    Bioorg Med Chem; 2005 Oct; 13(20):5787-96. PubMed ID: 15993614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives.
    Estrada-Soto S; Villalobos-Molina R; Aguirre-Crespo F; Vergara-Galicia J; Moreno-Díaz H; Torres-Piedra M; Navarrete-Vázquez G
    Life Sci; 2006 Jun; 79(5):430-5. PubMed ID: 16487544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
    Muller C; Endlich K; Barthelmebs M; Helwig JJ
    Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide.
    Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH
    Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.